Insider: Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS - Theravance Biopharma, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 255,999 | 0 | 255,999 |
| Value | $4,111,343.94 | $0.00 | $4,111,343.94 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/16/2026 | DDS | 7,767 | Direct | COM | $13.92 | $108,087.90 | 255,999 |
| 03/16/2026 | DDS | 15,534 | Direct | COM | $14.00 | $217,476.00 | 240,465 |
| 03/16/2026 | DDS | 7,766 | Direct | COM | $13.92 | $108,073.21 | 232,699 |
| 12/03/2025 | DDS | 7,767 | Direct | COM | $18.75 | $145,630.47 | 300,995 |
| 12/03/2025 | DDS | 7,766 | Direct | COM | $18.75 | $145,618.71 | 293,229 |
| 12/03/2025 | DDS | 15,534 | Direct | COM | $18.75 | $291,251.63 | 277,695 |
| 07/14/2025 | DDS | 682 | Direct | COM | $11.39 | $7,769.82 | 336,236 |
| 07/14/2025 | DDS | 5,318 | Direct | COM | $11.39 | $60,548.09 | 330,918 |
| 07/14/2025 | DDS | 4,000 | Direct | COM | $11.39 | $45,551.60 | 326,918 |
| 06/02/2025 | DDS | 24,000 | Direct | COM | $11.00 | $264,000.00 | 336,918 |
| 04/21/2025 | DDS | 4,000 | Direct | COM | $9.00 | $36,000.00 | 370,038 |
| 01/21/2025 | DDS | 4,000 | Direct | COM | $9.00 | $36,000.00 | 309,565 |
| 11/11/2024 | DDS | 4,000 | Direct | COM | $9.00 | $36,000.00 | 322,743 |
| 07/10/2024 | DDS | 4,000 | Direct | COM | $9.00 | $36,000.00 | 335,965 |
| 02/22/2024 | DDS | 1,254 | Direct | COM | $8.71 | $10,922.34 | 311,733 |
| 11/21/2023 | DDS | 1,378 | Direct | COM | $10.29 | $14,179.62 | 331,206 |
| 08/22/2023 | DDS | 1,807 | Direct | COM | $9.47 | $17,112.29 | 340,566 |
| 06/08/2023 | DDS | 1,790 | Direct | COM | $11.13 | $19,922.70 | 352,833 |
| 03/09/2023 | DDS | 4,000 | Direct | COM | $10.20 | $40,800.00 | 360,190 |
| 05/23/2022 | DDS | 1,081 | Direct | COM | $8.93 | $9,653.33 | 329,990 |
| 02/28/2022 | DDS | 2,356 | Direct | COM | $10.16 | $23,946.62 | 333,271 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research